Gulsen Kama

Insider Reports History

Entity
Individual
Location
C/O Bionano Genomics, Inc., 9540 Towne Centre Drive, Suite 100, San Diego, CA
Signature
/s/ Jonathan V. Dixon, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Gulsen Kama:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Bionano Genomics, Inc. Chief Financial Officer Common Stock 16K $20.3K $1.27 Jun 3, 2024 Direct
Bionano Genomics, Inc. Chief Financial Officer Stock Option (Right to Buy) 75K Jun 3, 2024 Direct
Bionano Genomics, Inc. Chief Financial Officer No securities are beneficially owned 0 Sep 11, 2023 Direct

Insider Reports Filed by Gulsen Kama

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BNGO Bionano Genomics, Inc. Jun 3, 2024 2 $0 4 Jun 5, 2024 Chief Financial Officer
BNGO Bionano Genomics, Inc. Sep 18, 2023 1 $0 4 Sep 20, 2023 Chief Financial Officer
BNGO Bionano Genomics, Inc. Sep 11, 2023 0 $0 3 Sep 20, 2023 Chief Financial Officer